The Changing Face of Colposcopy

Wednesday 29th June 2016

Discussion around how the introduction of HPV primary testing, vaccination and the use of adjunctive technologies are changing the face of colposcopy was a key focus at this year’s Royal College of Obstetricians and Gynaecologists (RCOG) World Congress.

In his presentation, ‘Colposcopy for cytology negative women: the changing colposcopy referral population and management’, Professor John Tidy discussed how HPV primary testing would have a short to medium term effect causing an increase in the number of referrals to colposcopy. Many of these would be HPV positive and cytology negative highlighting the need to explore adjunctive technologies to address this increase given the low prevalence of disease in this group.

The impact of HPV immunisation on screening and disease was also discussed by Professor Maggie Cruickshank. In her presentation, Professor Cruickshank said she believed ‘the overall uptake of HPV vaccination was good but the full effect would not be seen until 2054-2064 and therefore routine screening would need to continue for the foreseeable future.’


Editors Notes

For more information about Zilico please contact:
Zilico, tel: +44 161 826 7840; email: or visit

For Press enquiries please contact:
Julia Price  tel: +44 (0) 7737 864 878; e-mail: